A novel protein-engineered IL-12 shows efficacy without peripheral toxicity in animal models Nov. 24, 2021
ALTA-002, a Toll-like receptor agonist antibody conjugate with promising antitumor activity in vivo Nov. 24, 2021
Conference data for Nov. 23, 2021: SITC Nov. 23, 2021 Data presented at the Society for Immunotherapy of Cancer annual meeting – Nov. 10-14, including: Immutep.Read More
RSS